High levels of PSAT1 expression were associated with a poor prognosis in late-stage patients, whereas the other two genes did not have a prognostic value with regard to OS in patients with different stages of ccRCC (Fig. S1). This evidence concerns the gene PSAT1 and nonpapillary renal cell carcinoma.